SALL2 and colorectal carcinoma: Finally, we showed that SALL2 expression sensitizes CRC cells to death after treatment with a well-established Wnt signaling pathway inhibitor, highlighting the potential importance of SALL2 in the effectiveness of future Wnt-targeted therapies for CRC.